Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3Head and Neck Neoplasms 3Mouth Neoplasms 2Laryngeal Neoplasms 2Tongue Neoplasms 1Recurrent Head and Neck Carcinoma 1Precancerous Conditions 1Oropharyngeal Neoplasms 1Lymphoid Interstitial Pneumonia 1Leukoplakia, Oral 1Hypopharyngeal Neoplasms 1

Interventions

Cisplatin 5Platinum 4Cetuximab 41,2-diaminocyclohexaneplatinum II citrate 4Carboplatin 3Radiotherapy, Intensity-Modulated 2Nivolumab 2Immunoglobulin G 2Gemcitabine 2Gefitinib 2Fluorouracil 2Docetaxel 2Disulfides 2Biopsy 2Bevacizumab 2vandetanib 1temsirolimus 1linrodostat 1ficlatuzumab 1durvalumab 1dl1520 1dehydroftorafur 1cediranib 1atezolizumab 1adavosertib 1X-Rays 1Trioxsalen 1Specimen Handling 1Soybean Proteins 1Sirolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoid Interstitial Pneumonia × Dihematoporphyrin Ether × Head & Neck × Clear all
NCT02068157 2017-10-11

Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer

Roswell Park Cancer Institute

Phase 2 Terminated
3 enrolled 8 charts
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡